News BMS Wins First FDA Approval for CELMoD Class With Zenbexus in Multiple Myeloma pharminent August 14, 2026
News Eli Lilly Files Six Lawsuits to Combat Illegal Retatrutide Black Market pharminent August 12, 2026
News Trump Executive Order Strips Seven Vaccines From Childhood Immunization Recommendations pharminent August 11, 2026
News FDA Approves Moderna’s mFlusiva, the First mRNA-Based Seasonal Flu Vaccine pharminent August 6, 2026
News Eli Lilly Smashes Q2 Estimates, Raises 2026 Guidance to $85–$87B on GLP-1 Surge pharminent August 5, 2026
News Pfizer Axes Ex-Metsera Obesity Asset and GIPR Prospect in Quarterly Pipeline Clearout pharminent August 4, 2026
News AstraZeneca and Bristol Myers Squibb Reported to Have Held Mega-Merger Talks pharminent August 3, 2026
News Novo Nordisk’s Ziltivekimab Misses Primary Endpoint in Pivotal Cardiovascular Trial pharminent August 1, 2026
News Amgen’s Repatha Wins Positive CHMP Opinion for Preventing First Heart Attacks and Strokes pharminent July 30, 2026
News Vertex, AbCellera Partner on Next-Generation T-Cell Engagers for Autoimmune Disease pharminent July 29, 2026
News GSK Unveils Three-Year Restructuring to Fund Late-Stage R&D Ahead of Patent Cliff pharminent July 28, 2026
News AstraZeneca Says Drug Pricing Is ‘Evolving’ in Response to Trump’s Most-Favored-Nation Policy pharminent July 27, 2026
News EMA CHMP Recommends Twelve New Medicines for Approval at July 2026 Meeting pharminent July 24, 2026
News Lilly’s Retatrutide Hits 22.6% Weight Loss in Phase 3, But Cardiovascular Benefit Remains Elusive pharminent July 23, 2026
News Arrowhead’s Plozasiran Cuts Triglycerides Roughly 80% in Two Phase 3 Trials pharminent July 22, 2026
News Samsung Biologics Acquires Swiss CDMO PolyPeptide in $1.81bn All-Cash Deal pharminent July 20, 2026
News Merck Wins First FDA Approval of an Oral PCSK9 Inhibitor with Cholesterol Pill Lipfendra pharminent July 16, 2026
News J&J Beats Q2 Estimates, Raises Full-Year Guidance on Innovative Medicine Strength pharminent July 15, 2026
News Biogen’s Tau-Targeting Alzheimer’s Data Show Promise — and Raise Questions pharminent July 14, 2026
News Roche Scraps Two Ionis-Partnered Huntington’s Studies After Tominersen Failure pharminent July 10, 2026
News Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK pharminent July 8, 2026
News BioNTech Held Buyer Talks Over Four German Sites Set to Close, Handelsblatt Reports pharminent July 3, 2026
News Roche’s Divarasib Beats Amgen and BMS Head-to-Head in Phase 3 KRAS Lung Cancer Trial pharminent July 2, 2026
